Personal care company Nu Skin (NYSE:NUS) will be announcing earnings results tomorrow afternoon. Here’s what to expect. Nu Skin beat analysts’ revenue expectations by 2.2% last quarter, reporting revenues of $445.6 million, down 8.8% year on year. It was a slower quarter for the company, with revenue guidance for next quarter missing analysts’ expectations and a significant miss of analysts’ gross margin estimates. Is Nu Skin a buy or sell going into earnings? Read our full analysis here, it’s free.Nu Skin Total Revenue Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Nu Skin has missed Wall Street’s revenue estimates four times over the last two years. Looking at Nu Skin’s peers in the personal care segment, some have already reported their Q1 results, giving us a hint as to what we can expect. USANA delivered year-on-year revenue growth of 9.5%, beating analysts’ expectations by 2.7%, and Estée Lauder reported a revenue decline of 9.9%, topping estimates by 1.2%. USANA traded up 5.2% following the results while Estée Lauder’s stock price was unchanged. Read our full analysis of USANA’s results here and Estée Lauder’s results here. There has been positive sentiment among investors in the personal care segment, with share prices up 4.9% on average over the last month. Nu Skin is down 4% during the same time. Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. View Comments
Earnings To Watch: Nu Skin (NUS) Reports Q1 Results Tomorrow
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...